Skip to Main Content

Basic & Clinical Research

Researchers at the USF Health Morsani College of Medicine and Tampa General Hospital are conducting a study to determine if a pair of anti-fibrotic medications are effective at helping patients living with idiopathic pulmonary fibrosis (IPF), a chronic condition that leads to scarring of the lungs.

Debabrata Bandyopadhyay, MD, associate professor in the Division of Pulmonary and Critical Care at the USF Health Morsani College of Medicine and director of the Interstitial Lung Disease and Sarcoidosis Program at Tampa General Hospital, is leading the current study. He said this trial is dedicated to enhancing the quality of life for individuals living with pulmonary fibrosis. 

To learn more about this study, please read the story on how: USF and TGH Seek Participants for Pulmonary Fibrosis Drug Trial


The Division of Pulmonary, Critical Care & Sleep Medicine is dedicated to healthcare advances through scientific research, in addition to clinical research. The research conducted is of compassionate care for patients with critical illness, thoracic diseases and sleep-related disorders. Through clinical research faculty, research associates, and staff can exemplify years of dedicated time and experiences to progress medicine with patients who meet the needs of the division’s specialties.

The Chief of Pulmonary, Critical Care and Sleep Medicine is Dr. Jose D. Herazo-Maya, who is highly trained in functional genomics, molecular biology and bioinformatics. He pioneered the application of precision medicine to identify molecular predictors of Idiopathic Pulmonary Fibrosis (IPF) and COVID-19 mortality.

Tampa General Hospital + USF Health

To schedule a patient appointment, call
(813) 821-8033

Tampa General Hospital is the best hospital of the Tampa Bay region and is a leading academic medical center that is ranked among the top centers nationally. The Department performs basic and translational scientific research, as well as clinical research.

The basic and translational research includes:

Our department is currently enrolling patients in numerous clinical trials, including for patients with interstitial lung disease, pulmonary arterial hypertension, and nontuberculous mycobacteria. To see if you might qualify for one of these studies, we encourage you to contact our clinic to schedule an appointment with one of our providers.